FABP4 and obesity disorder: One innovative approach in obesity research involves using a nonviral, adipose tissue-targeted gene delivery system to guide a CRISPRi complex toward white adipocytes, aiming to silence fatty acid-binding protein 4 (Fabp4)—a key regulator of lipid handling.